Novo Nordisk shares rose nearly 5% in premarket trading after the company launched its Wegovy weight-loss pill in the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback